Posted on Tuesday, April 15, 2014 at 2:30 pm CDT
EntraCell Pharmacy, Inc. is excited to introduce their dynamic new website – www.EntraCellPharmacy.com. This new-media approach to the traditional pharmacy gives the customers a convenient option to order and receive their pain management, wound care and scar treatment creams and gels.
Source: dwgPR
Posted on Tuesday, April 15, 2014 at 2:29 pm CDT

Global Markets Direct's, 'Compugen Ltd. - Product Pipeline Review - 2014', provides an overview of the Compugen Ltd.'s pharmaceutical research and development focus.
Source: Fast Market Research
Posted on Tuesday, April 15, 2014 at 2:29 pm CDT

Global Markets Direct's, 'Alzheimer's Disease - Pipeline Review, H1 2014', provides an overview of the Alzheimer's Disease's therapeutic pipeline.
Source: Fast Market Research
Posted on Tuesday, April 15, 2014 at 2:24 pm CDT

Global Markets Direct's, 'Collegium Pharmaceutical, Inc. - Product Pipeline Review - 2014', provides an overview of the Collegium Pharmaceutical, Inc.'s pharmaceutical research and development focus.
Source: Fast Market Research
Posted on Tuesday, April 15, 2014 at 2:23 pm CDT

Global Markets Direct's, 'Serodus ASA - Product Pipeline Review - 2014', provides an overview of the Serodus ASA's pharmaceutical research and development focus.
Source: Fast Market Research
Posted on Tuesday, April 15, 2014 at 2:19 pm CDT

Global Markets Direct's, 'Torrent Pharmaceuticals Limited - Product Pipeline Review - 2014', provides an overview of the Torrent Pharmaceuticals Limited's pharmaceutical research and development focus.
Source: Fast Market Research
Posted on Tuesday, April 15, 2014 at 2:15 pm CDT

Global Markets Direct's, 'Febrile Neutropenia - Pipeline Review, H1 2014', provides an overview of the Febrile Neutropenia's therapeutic pipeline.
Source: Fast Market Research
Posted on Tuesday, April 15, 2014 at 2:06 pm CDT

Global Markets Direct's, 'Medulloblastoma - Pipeline Review, H1 2014', provides an overview of the Medulloblastoma's therapeutic pipeline.
Source: Fast Market Research
Posted on Tuesday, April 15, 2014 at 1:08 pm CDT

Global Markets Direct's, 'Parkinson's Disease - Pipeline Review, H1 2014', provides an overview of the Parkinson's Disease's therapeutic pipeline.
Source: Fast Market Research
Posted on Tuesday, April 15, 2014 at 12:54 pm CDT

Global Markets Direct's, 'Rotavirus Infections - Pipeline Review, H1 2014', provides an overview of the Rotavirus Infections's therapeutic pipeline.
Source: Fast Market Research
Posted on Tuesday, April 15, 2014 at 12:25 pm CDT

Global Markets Direct's, 'Small-Cell Lung Cancer - Pipeline Review, H1 2014', provides an overview of the Small-Cell Lung Cancer's therapeutic pipeline.
Source: Fast Market Research
Posted on Tuesday, April 15, 2014 at 12:24 pm CDT

Global Markets Direct's, 'Medullary Thyroid Cancer - Pipeline Review, H1 2014', provides an overview of the Medullary Thyroid Cancer's therapeutic pipeline.
Source: Fast Market Research
Posted on Tuesday, April 15, 2014 at 12:17 pm CDT

Global Markets Direct's, 'Ulcerative Colitis - Pipeline Review, H1 2014', provides an overview of the Ulcerative Colitis's therapeutic pipeline.
Source: Fast Market Research
Posted on Tuesday, April 15, 2014 at 12:07 pm CDT

Global Markets Direct's, 'Varicella Zoster (HHV-3) Infections - Pipeline Review, H1 2014', provides an overview of the Varicella Zoster (HHV-3) Infections's therapeutic pipeline.
Source: Fast Market Research
Posted on Tuesday, April 15, 2014 at 11:47 am CDT
Phil Sanderson, founder of Drugeo, announced the launch of his new search engine to assist consumers locate the best price for prescription and generic drugs. The website is free to use. Individuals simply enter the name of a drug and hit search to compare drug prices across multiple pharmacies.
Source: PR Apex
Posted on Tuesday, April 15, 2014 at 11:45 am CDT

Global Markets Direct's, 'Bolder Biotechnology, Inc. - Product Pipeline Review - 2014', provides an overview of the Bolder Biotechnology, Inc.'s pharmaceutical research and development focus.
Source: Fast Market Research
Posted on Tuesday, April 15, 2014 at 11:44 am CDT

Global Markets Direct's, 'Familial Adenomatous Polyposis Coli - Pipeline Review, H1 2014', provides an overview of the Familial Adenomatous Polyposis Coli's therapeutic pipeline.
Source: Fast Market Research
Posted on Tuesday, April 15, 2014 at 11:37 am CDT

Global Markets Direct's, 'Cirrhosis - Pipeline Review, H1 2014', provides an overview of the Cirrhosis's therapeutic pipeline.
Source: Fast Market Research
Posted on Tuesday, April 15, 2014 at 11:35 am CDT

Global Markets Direct's, 'Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2014', provides an overview of the Metastatic Renal Cell Carcinoma's therapeutic pipeline.
Source: Fast Market Research
Posted on Tuesday, April 15, 2014 at 11:28 am CDT

Global Markets Direct's, 'Jeil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the Jeil Pharmaceutical Co., Ltd.'s pharmaceutical research and development focus.
Source: Fast Market Research
Posted on Tuesday, April 15, 2014 at 11:10 am CDT

Global Markets Direct's, 'Botulism - Pipeline Review, H1 2014', provides an overview of the Botulism's therapeutic pipeline.
Source: Fast Market Research
Posted on Tuesday, April 15, 2014 at 10:41 am CDT

Global Markets Direct's, 'Lupin Limited - Product Pipeline Review - 2014', provides an overview of the Lupin Limited's pharmaceutical research and development focus.
Source: Fast Market Research
Posted on Tuesday, April 15, 2014 at 9:53 am CDT

Global Markets Direct's, 'Cholera - Pipeline Review, H1 2014', provides an overview of the Cholera's therapeutic pipeline.
Source: Fast Market Research
Posted on Tuesday, April 15, 2014 at 9:23 am CDT

Global Markets Direct's, 'Skin Inflammation - Pipeline Review, H1 2014', provides an overview of the Skin Inflammation's therapeutic pipeline.
Source: Fast Market Research
Posted on Tuesday, April 15, 2014 at 9:15 am CDT

Global Markets Direct's, 'Synta Pharmaceuticals Corp. - Product Pipeline Review - 2014', provides an overview of the Synta Pharmaceuticals Corp.'s pharmaceutical research and development focus.
Source: Fast Market Research